Evidence map›Paper›PMID 40320790›Full record

ArticleJournal of Alzheimer's disease : JAD2025

Modeling Alzheimer's disease: Bayesian copula graphical model from demographic, cognitive, and neuroimaging data.

Lucas Vogels, Reza Mohammadi, Marit Schoonhoven, Ş Ilker Birbil, Martin Dyrba, Alzheimer’s Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lucas VogelsAmsterdam Business School, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0009-0005-3715-3937
Reza MohammadiAmsterdam Business School, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-9538-0648
Marit SchoonhovenAmsterdam Business School, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-2268-7486
Ş Ilker BirbilAmsterdam Business School, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-7472-7032
Martin DyrbaGerman Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.ORCID 0000-0002-3353-3167
Alzheimer’s Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type DementiasRF1AG051550 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F, KLING, MITCHEL ALLAN · 2015 to 2016
$6.3M
Metabolic Networks and Pathways in Alzheimer's DiseaseR01AG046171 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F · 2014 to 2017
$4.4M
NIA NIH HHS R01 AG046171NIA NIH HHS RF1 AG051550NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

BackgroundThe early detection of Alzheimer's disease (AD) requires an understanding of the relationships between a wide range of features. Conditional independencies and partial correlations are suitable measures for these relationships, because they can identify the effects of confounding and mediating variables.ObjectiveTo estimate conditional dependencies and partial correlations between relevant features in AD using a Bayesian approach to Gaussian copula graphical models (GCGMs). This approach has two key advantages. First, it includes binary, discrete, and continuous variables. Second, it quantifies the uncertainty of the estimates. Despite these advantages, Bayesian GCGMs have not been applied to AD research yet.MethodsWe design a GCGM to find the conditional dependencies and partial correlations among brain-region specific gray matter volume and glucose uptake, amyloid-beta levels, demographic information, and cognitive test scores. We applied our model to

Indexed as

Alzheimer DiseaseBrainCognitionNeuroimagingAgedAged, 80 and overAmyloid beta-PeptidesBayes TheoremCognitive DysfunctionFemaleGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsAmyloid beta-PeptidesAlzheimer’s diseasebrain connectivityconditional dependencylink predictionmodel uncertaintypartial correlation

Identifiers

PMID40320790
PMCPMC12583651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.